Aerie Pharmaceuticals, Inc. (AERI): Price and Financial Metrics
AERI Price/Volume Stats
| Current price | $15.25 | 52-week high | $15.37 |
| Prev. close | $15.24 | 52-week low | $4.81 |
| Day low | $15.24 | Volume | 1,215,100 |
| Day high | $15.25 | Avg. volume | 974,748 |
| 50-day MA | $15.19 | Dividend yield | N/A |
| 200-day MA | $10.11 | Market Cap | 753.61M |
AERI Stock Price Chart Interactive Chart >
Aerie Pharmaceuticals, Inc. (AERI) Company Bio
Aerie Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. The company was founded in 2005 and is based in Irvine, California.
AERI Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | 51.89% |
| 5-year | -17.12% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | 0.00% |
| 2021 | -48.04% |
| 2020 | -44.10% |
| 2019 | -33.05% |
Continue Researching AERI
Want to see what other sources are saying about Aerie Pharmaceuticals Inc's financials and stock price? Try the links below:Aerie Pharmaceuticals Inc (AERI) Stock Price | Nasdaq
Aerie Pharmaceuticals Inc (AERI) Stock Quote, History and News - Yahoo Finance
Aerie Pharmaceuticals Inc (AERI) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...